A £3.2 million grant from the Wellcome Trust will enable multiple partners around the world to quickly establish clinical trials at existing Ebola treatment centres. Partners include the International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC), the University of Oxford, Médecins Sans Frontières (MSF), the World Health Organization (WHO), Institut Pasteur, Institut Pasteur de Dakar, Fondation Mérieux and the Global Health Network.
In August a WHO expert panel unanimously concluded that in such exceptional circumstances it would be ethical to evaluate unregistered investigational treatments in people with Ebola virus disease.
Several potential interventions have shown promise in the laboratory, in animal studies on non-human primates, and in a small number of cases of compassionate intervention, but none has yet been tested for efficacy and safety in humans with Ebola. Any new drug needs to be evaluated within the rigorous settings of a clinical trial to assess whether it is doing more harm or good.
The belief system of the global medical system cannot entertain the simpler solutions. We can with high confidence state, that Intravenous Vitamin C, collodial/nano silver and natural antiviral oils would be safer as treatment protocols and would provide the validation of these solutions that these medical priests state they seek for corporate “unregistered investigational treatment”.
Further evidence of the collusion of academia and funding foundations in the fraud that are vaccines.
Intravenous vitamin C should be given to all Ebola patients. Though it has not been studied, I have no doubt that IV vitamin C would be a great benefit to any patient suffering not only from Ebola but from any infectious agent. In my practice, I have used IV vitamin C for over 20 years. Anytime the body is stressed, vitamin C requirements are elevated. IV vitamin C achieves a much higher serum level as compared to oral vitamin C. IV vitamin C should be a standard-of-care treatment for all Ebola patients. In fact, it should be standard-of-care for any hospitalized patient.
Nurse Pineo, the first white that survived the Lassa fever (another hemorrhagic fever) outbreak in Lassa, was, on her own, taking vitamins (Fuller, JG. Fever. Reader’s Digest Press. 1974.) Of course that was ignored and they used her convalescent serum for subsequent cases of Lassa fever in medical personnel.
Vitamin C experts such as Dr. Robert Cathcart, III, MD and Dr. Thomas E Levy, MD, JD have published their ideas for treating the Ebola virus with high dosages of Vitamin C. They have noted that the symptoms of the Ebola virus are similar to a very rapid and powerful scurvy (i.e. a super-vitamin C defiency). Even if this isn’t the primary action of the virus, the effect is the same because any powerful viral infection will deplete ascorbate tissues stores per Dr. Cathcart’s Titrating Vitamin C to Bowel Tolerance finding. The sicker a person is, the more vitamin C they can tolerate without diarrhea
With thousands infected with the Ebola virus, millions of dollars are being pledged to develop treatment options. Three avenues that have potential but are a long way from being viable treatments.
Plasma (Survivor Blood)
Vaccine (Ebola fragments)
Vitamin C (Intravenous, Lyposomal)
Other Immune Boosting supplements/AntiOxidants
Here is the treatment, complete with MOA. This is a treatment and not a cure, your immune system wipes out the virus, and the treatment gives your immune system time to do it. Here is what Ebola does that is fatal: It causes the complete removal of all vitamin C from the body. No one actually knows what mechanism is involved in doing this, other than a malfunction that is not permanently destructive to whatever is triggered to remove all vitamin C. All the researchers know is that vitamin C drops to zero and all the symptoms of ebola are consistent with a complete loss of vitamin C.